checkAd

    EQS-Adhoc  862  0 Kommentare HOCHDORF Holding Ltd: Signing of agreement and extraordinary General Meeting - Seite 2


    registering and voting restriction from 5% to 15%.

    The HOCHDORF Holding Ltd shareholders will decide on the amendments to the
    Articles of Association at the Extraordinary General Meeting of 29 November
    2016. Invitations to the meeting will be sent out over the next few days.

    Michiel de Ruiter's election as additional board member
    The election of Michiel de Ruiter as an additional board member will also
    be recommended to the Extraordinary General Meeting. De Ruiter was
    responsible for developing the HOCHDORF Group's international business in
    infant formula between 2006 and 2014. Currently the CEO of the Zeelandia
    Group, which is active in 27 countries and has its headquarters in the
    Netherlands, de Ruiter is a proven expert in infant formula and would
    strengthen the Board of Directors in this important growth area.

    Additional features:


    Document: http://n.eqs.com/c/fncls.ssp?u=QWQHAEDPRF
    Document title: Media Release: Signing HOCHDORF - Pharmalys

    ---------------------------------------------------------------------------

    End of ad hoc announcement

    ---------------------------------------------------------------------------


    Information and Explanation of the Issuer to this News:

    About the HOCHDORF Group
    The HOCHDORF Group, based in Hochdorf, achieved a consolidated gross sales
    revenue of CHF 551.2 million in 2015. It is one of the leading foodstuff
    companies in Switzerland, employing 625 staff as of 31.12.2015. Made from
    natural ingredients such as milk, wheat germ and oil seeds, HOCHDORF
    products have been contributing to our health and wellbeing since 1895 -
    from babies to senior citizens. Its customers include the food industry and
    the wholesale and retail sectors. Its products are sold in over 90
    countries. The shares are traded on the SIX Swiss Exchange in Zurich (ISIN
    CH0024666528).

    About the Pharmalys Group
    Pharmalys is a rapidly-growing concern and has been a HOCHDORF customer
    since 2008. The Pharmalys Group has a staff of more than 500 direct
    and indirect employees around the world. The company markets infant
    nutrition under the Primalac brand; it also markets infant nutrition and
    cereals under the Swisslac brand. Its products are available in 42
    countries in Europe, Asia, Africa and the Middle East. Pharmalys
    Laboratories SA has its headquarters in Baar (Switzerland). Pharmalys
    Tunisia SA and Pharmalys Africa Sarl, which is still to be founded as part
    of a joint venture, are both located in Tunis (Tunisia).


    ---------------------------------------------------------------------------

    Language: English
    Company: HOCHDORF Holding AG
    Siedereistrasse 9
    6281 Hochdorf
    Switzerland
    Phone: +41 41 914 65 65
    Fax: +41 41 914 66 66
    E-mail: hochdorf@hochdorf.com
    Internet: www.hochdorf.com
    ISIN: CH0024666528
    Listed: SIX Swiss Exchange


    End of News EQS Group News Service
    ---------------------------------------------------------------------------

    508739 25.10.2016
    Seite 2 von 2


    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-Adhoc HOCHDORF Holding Ltd: Signing of agreement and extraordinary General Meeting - Seite 2 EQS Group-Ad-hoc: HOCHDORF Holding AG / Key word(s): Takeover/AGM/EGM HOCHDORF Holding Ltd: Signing of agreement and extraordinary General Meeting 25.10.2016 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. …